AuntMinnie

MARCH 7, 2024

year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging. IMV's 2024 PET Market Summary Report explores market trends in U.S.

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 52

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 52

Imaging Technology

MAY 29, 2024

milla1cf Wed, 05/29/2024 - 07:00 May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent radiology practices with the addition of 14-radiologist Riverside Radiology Medical Group (RRMG). For more information: www.strategicradiology.org Wednesday, May 29, 2024 - 07:00

Medical 52

Medical Nuclear Medicine Radiology Hospital 52

AuntMinnie

JUNE 11, 2024

He presented the abstract on behalf of first author Ken Herrmann, MD, chair of nuclear medicine at the University Hospital Essen in Essen, Germany. This is really a critical presentation from my perspective about the importance [of nuclear medicine] in multidisciplinary care,” Sartor said. “It

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

Vesta Teleradiology

JANUARY 12, 2024

These events provide a platform for experts in each imaging domain to share groundbreaking research, exchange innovative ideas, and explore the latest technological advancements in various modalities such as X-ray, MRI, CT scans, ultrasound, and nuclear medicine. Here’s a small list of events you may want to check out!

X-ray 49

X-ray Imaging Education Nuclear Medicine 49

AuntMinnie

APRIL 4, 2024

Thomas Hope, MD, a radiologist and nuclear medicine physician at the University of California, San Francisco (UCSF), said that approval of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand has driven a marked interest and excitement about theranostics and radioligand therapies (RLT). Hope added. Hope added.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 Food and Drug Administration.

Clinic 81

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 81

Imaging Technology

JULY 3, 2024

christine.book Wed, 07/03/2024 - 12:53 July 3, 2024 — A new Harvey L. of nuclear medicine (NM), and 33.9% of nuclear medicine (NM), and 33.9% More information: www.neimanhpi.org Wednesday, July 3, 2024 - 12:53 Neiman Health Policy Institute ( HPI ) study found that radiologists interpreted 72.1%

Image Interpretation 92

Image Interpretation Radiologist Imaging Ultrasound 92

AuntMinnie

JUNE 8, 2024

An emerging radioligand therapy could be particularly effective for controlling advanced sarcoma compared to other cancers, according to research presented June 8 in a Young Investigator Award session at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Toronto.

Nuclear Medicine 98

Nuclear Medicine Disease Radiation Hospital 98

AuntMinnie

JUNE 9, 2024

Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

FEBRUARY 1, 2024

The American Roentgen Ray Society (ARRS) is awarding its two 2024 ARRS Scholarships to Ian Mark, MD, of Mayo Clinic Minnesota and Evan Calabrese, MD, PhD, of Duke University Medical Center. Ian Mark, MD. Image courtesy of the ARRS.

Nuclear Medicine 52

Nuclear Medicine Clinic Diagnostic Hospital 52

Imaging Technology

JUNE 20, 2024

For the practice of precision care in molecular imaging and nuclear medicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.

Healthcare 81

Healthcare Healthcare Nuclear Medicine Computed Tomography 81

AuntMinnie

JUNE 12, 2024

A PET-based scout dosimetry protocol can be feasible in treating lesions with yttrium-90 (Y-90) fibroblast activation protein inhibitor (FAPI) radioligand therapy, according to research presented June 11 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

Nuclear Medicine 59

Nuclear Medicine Radiation Hospital Diagnostic 59

Imaging Technology

JANUARY 8, 2024

These efforts are reflected in the company’s mission to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. GE HealthCare intends to fund this transaction with cash on hand.

Healthcare 91

Healthcare Healthcare Radiation Oncology Radiation 91

Imaging Technology

APRIL 24, 2024

The findings were published in Clinical Nuclear Medicine. For more information: [link] Wednesday, April 24, 2024 - 19:24 It means our approach is relevant clinically.”

PET Scan 75

PET Scan Disease Nuclear Medicine Clinic 75

AuntMinnie

JUNE 3, 2024

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

MARCH 29, 2024

With the passage of the Consolidated Appropriations Act, 2024 (CAA 24) , we finally learned the rates physicians will be paid for Medicare services during the remainder of 2024. This makes the Medicare payment rate 1.77% lower than it was in 2023, rather than the 3.37% cut that was contained in the 2024 MPFS Final Rule.

Medicare 111

Medicare Radiology Mammogram X-ray 111

AuntMinnie

JANUARY 19, 2024

For the hospital outpatient setting, Medicare currently packages the payment for radiopharmaceuticals into an overall payment for groupings of nuclear medicine procedures including PET. Stakeholders will continue to work with the agency so that hospital outpatient facilities are adequately reimbursed in the future.

Disease 52

Disease Medicare Imaging PET Scan 52

Imaging Technology

APRIL 3, 2023

Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine. The Accelerator Production facility is expected to come online, upon completion of regulatory submissions, in late 2023/early 2024.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82